Ahn Yoon Hae, Lee Jinwoo, Oh Dong Kyu, Lee Su Yeon, Park Mi Hyeon, Lee Haein, Lim Chae-Man, Lee Sang-Min, Lee Hong Yeul
Department of Critical Care Medicine, Seoul National University Hospital, 101 Daehak-Ro, Jongno-Gu, Seoul, 03080, Korea.
Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Seoul National University Hospital, Seoul, Korea.
J Intensive Care. 2023 Apr 21;11(1):16. doi: 10.1186/s40560-023-00663-6.
Based on sparse evidence, the current Surviving Sepsis Campaign guideline suggests that critically ill patients with sepsis be admitted to the intensive care unit (ICU) within 6 h. However, limited ICU bed availability often makes immediate transfer difficult, and it is unclear whether all patients will benefit from early admission to the ICU. Therefore, the purpose of this study was to determine the association between the timing of ICU admission and mortality in patients with hospital-onset sepsis.
This nationwide prospective cohort study analyzed patients with hospital-onset sepsis admitted to the ICUs of 19 tertiary hospitals between September 2019 and December 2020. ICU admission was classified as either early (within 6 h) or delayed (beyond 6 h). The primary outcome of in-hospital mortality was compared using logistic regression adjusted for key prognostic factors in the unmatched and 1:1 propensity-score-matched cohorts. Subgroup and interaction analyses assessed whether in-hospital mortality varied according to baseline characteristics.
A total of 470 and 286 patients were included in the early and delayed admission groups, respectively. Early admission to the ICU did not significantly result in lower in-hospital mortality in both the unmatched (adjusted odds ratio [aOR], 1.35; 95% confidence interval [CI], 0.99-1.85) and matched cohorts (aOR, 1.38; 95% CI, 0.94-2.02). Subgroup analyses showed that patients with increasing lactate levels (aOR, 2.10; 95% CI, 1.37-3.23; P for interaction = 0.003), septic shock (aOR, 2.06; 95% CI, 1.31-3.22; P for interaction = 0.019), and those who needed mechanical ventilation (aOR, 1.92; 95% CI, 1.24-2.96; P for interaction = 0.027) or vasopressor support (aOR, 1.69; 95% CI, 1.17-2.44; P for interaction = 0.042) on the day of ICU admission had a higher risk of mortality with delayed admission.
Among patients with hospital-onset sepsis, in-hospital mortality did not differ significantly between those with early and delayed ICU admission. However, as early intensive care may benefit those with increasing lactate levels, septic shock, and those who require vasopressors or ventilatory support, admission to the ICU within 6 h should be considered for these subsets of patients.
基于稀少的证据,当前的拯救脓毒症运动指南建议,患有脓毒症的危重症患者应在6小时内入住重症监护病房(ICU)。然而,ICU床位有限常常使立即转运变得困难,而且尚不清楚所有患者是否都能从早期入住ICU中获益。因此,本研究的目的是确定医院获得性脓毒症患者的ICU入住时间与死亡率之间的关联。
这项全国性的前瞻性队列研究分析了2019年9月至2020年12月期间入住19家三级医院ICU的医院获得性脓毒症患者。ICU入住被分为早期(6小时内)或延迟(超过6小时)。使用逻辑回归对未匹配和1:1倾向评分匹配队列中的关键预后因素进行调整后,比较住院死亡率这一主要结局。亚组分析和交互作用分析评估了住院死亡率是否因基线特征而异。
早期和延迟入住组分别纳入了470例和286例患者。在未匹配队列(调整后的优势比[aOR],1.35;95%置信区间[CI],0.99 - 1.85)和匹配队列(aOR,1.38;95%CI,0.94 - 2.02)中,早期入住ICU均未显著降低住院死亡率。亚组分析表明,入住ICU当天乳酸水平升高(aOR,2.10;95%CI,1.37 - 3.23;交互作用P值 = 0.003)、脓毒性休克(aOR,2.06;95%CI,1.31 - 3.22;交互作用P值 = 0.019)以及需要机械通气(aOR,1.92;95%CI,1.24 - 2.96;交互作用P值 = 0.027)或血管活性药物支持(aOR,1.69;95%CI,1.17 - 2.44;交互作用P值 = 0.042)的患者,延迟入住时死亡风险更高。
在医院获得性脓毒症患者中,早期和延迟入住ICU的患者住院死亡率无显著差异。然而,由于早期强化治疗可能使乳酸水平升高、脓毒性休克以及需要血管活性药物或通气支持的患者获益,对于这些亚组患者,应考虑在6小时内入住ICU。